Exclusion of WWP1 mutations in a cohort of dystroglycanopathy patients

Muscle Nerve. 2011 Sep;44(3):388-92. doi: 10.1002/mus.22068.

Abstract

Introduction: Aberrant glycosylation of α-dystroglycan is associated with a subset of clinically heterogeneous muscular dystrophies collectively referred to as the dystroglycanopathies. These autosomal-recessive disorders span a wide spectrum of clinical severity ranging from Walker-Warburg syndrome, with severe brain and eye abnormalities, to mild adult-onset limb-girdle muscular dystrophy. To date, seven causative genes have been identified in the dystroglycanopathies, yet studies have suggested that a significant proportion of patients harbor mutations in novel genes.

Methods: A homozygous missense alteration in the gene encoding ubiquitin ligase WW domain-containing protein 1 (WWP1), has recently been identified in the dystroglycanopathy chicken. We therefore investigated whether mutations in the human ortholog were present in a cohort of 33 dystroglycanopathy patients.

Results: No clear pathogenic mutations were identified.

Conclusion: The present findings indicate that WWP1 is not a common cause of human dystroglycanopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Dystroglycans / metabolism*
  • Genetic Testing
  • Glycosylation
  • Homozygote
  • Humans
  • Muscle, Skeletal / metabolism
  • Muscular Dystrophies / genetics*
  • Muscular Dystrophies / metabolism*
  • Mutation, Missense / genetics*
  • Sequence Analysis, DNA
  • Ubiquitin-Protein Ligases / genetics*

Substances

  • DAG1 protein, human
  • Dystroglycans
  • WWP1 protein, human
  • Ubiquitin-Protein Ligases